Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion type Assertion NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_head.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion wasGeneratedBy ECO_0000203 NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_provenance.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion wasDerivedFrom gad-20150221 NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_provenance.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion SIO_000772 19493232 NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_provenance.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion evidence source_evidence_literature NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_provenance.
- NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_assertion description "[Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148687.RA8EdxVRBesyTXx83pRHiZQeBUR5gS43r1EjmW65wPUAg130_provenance.